Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.56 (
caspase-3
)
35,750
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Progression of the cell cycle and control of apoptosis (programmed cell death) are thought to be intimately linked processes, acting to preserve homeostasis and developmental morphogenesis. Although proteins that regulate apoptosis have been implicated in restraining cell-cycle entry and controlling ploidy (chromosome number), the effector molecules at the interface between cell proliferation and cell survival have remained elusive. Here we show that a new inhibitor of apoptosis (IAP) protein,
survivin
, is expressed in the G2/M phase of the cell cycle in a cycle-regulated manner. At the beginning of mitosis,
survivin
associates with microtubules of the mitotic spindle in a specific and saturable reaction that is regulated by microtubule dynamics. Disruption of
survivin
-microtubule interactions results in loss of
survivin
's anti-apoptosis function and increased
caspase-3
activity, a mechanism involved in cell death, during mitosis. These results indicate that
survivin
may counteract a default induction of apoptosis in G2/M phase. The overexpression of
survivin
in cancer may overcome this apoptotic checkpoint and favour aberrant progression of transformed cells through mitosis.
...
PMID:Control of apoptosis and mitotic spindle checkpoint by survivin. 985 93
Here we investigate the role of the control of apoptosis in normal cell division. We show that interference with the expression or function of the apoptosis inhibitor survivin causes caspase-dependent cell death in the G2/M phase of the cell cycle, and a cell-division defect characterized by centrosome dysregulation, multipolar mitotic spindles and multinucleated, polyploid cells. Use of a dominant-negative
survivin
mutant or antisense
survivin
complementary DNA disrupts a supramolecular assembly of
survivin
,
caspase-3
and the cyclin-dependent-kinase inhibitor p21Waf1/Cip1 within centrosomes, and results in caspase-dependent cleavage of p21. Polyploidy induced by
survivin
antagonists is accentuated in p21-deficient cells, and corrected by exogenous expression of p21. These findings show that control of apoptosis and preservation of p21 integrity within centrosomes by
survivin
are required for normal mitotic progression.
...
PMID:Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. 1058 56
Survivin is a member of the inhibitor of apoptosis protein (IAP) family that is believed to play a role in oncogenesis. To elucidate further its physiologic role(s), we have characterized the murine
survivin
gene and complementary DNA (cDNA). The structural organization of the
survivin
gene, located on chromosome 11E2, is similar to that of its human counterpart, both containing 4 exons. Surprisingly, 3 full-length murine
survivin
cDNA clones were isolated, predicting the existence of 3 distinct
survivin
proteins. The longest open reading frame, derived from all 4 exons, predicts a 140-amino acid residue protein,
survivin
(140), similar to human
survivin
, which contains a single IAP repeat and a COOH-terminal coiled-coil domain that links its function to the cell cycle. A second cDNA, which retains intron 3, predicts the existence of a 121-amino acid protein,
survivin
(121) that lacks the coiled-coil domain. Removal of exon 2-derived sequences by alternative pre-messenger RNA (mRNA) splicing results in a third 40-amino acid residue protein,
survivin
(40), lacking the IAP repeat and coiled-coil structure. Predictably, only recombinant
survivin
(140) and
survivin
(121) inhibited
caspase-3
activity. All 3 mRNA species were variably expressed during development from 7.5 days postcoitum. Of the adult tissues surveyed, thymus and testis accumulated high levels of
survivin
(140) mRNA, whereas
survivin
(121)-specific transcripts were detected in all tissues, while those representing
survivin
(40) were absent. Human counterparts to the 3
survivin
mRNA transcripts were identified in a study of human cells and tissues. The presence of distinct isoforms of
survivin
that are expressed differentially suggests that
survivin
plays a complex role in regulating apoptosis. (Blood. 2000;95:1435-1442)
...
PMID:Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions. 1118 74
Mechanisms controlling endothelial cell survival during angiogenesis were investigated. Stimulation of quiescent endothelial cells with mitogens, including vascular endothelial growth factor and basic fibroblast growth factor, induced up to approximately 16-fold up-regulation of the cell cycle-regulated apoptosis inhibitor survivin. Mitogen stimulation rapidly increased
survivin
RNA expression in endothelial cells, which peaked after 6 to 10 hours in culture and decreased by 24 hours. Inflammatory cytokines, tumor necrosis factor alpha, and interleukin-1 did not induce
survivin
expression in endothelial cells. Formation of three-dimensional vascular tubes in vitro was associated with strong induction of
survivin
in endothelial cells, as compared with two-dimensional cultures. By immunohistochemistry,
survivin
was minimally expressed in endothelium of nonproliferating capillaries of normal skin, whereas it became massively up-regulated in newly formed blood vessels of granulation tissue in vivo. Recombinant expression of green fluorescent protein
survivin
in endothelial cells reduced
caspase-3
activity and counteracted apoptosis induced by tumor necrosis factor alpha/cycloheximide. These findings identify
survivin
as a novel growth factor-inducible protective gene expressed by endothelial cells during angiogenesis. Therapeutic manipulation of
survivin
expression and function in endothelium may influence compensatory or pathological (tumor) angiogenesis.
...
PMID:Control of apoptosis during angiogenesis by survivin expression in endothelial cells. 1066 67
Survivin, an inhibitor of apoptosis protein, deserves attention as a selective target for cancer therapy because it lacks expression in differentiated adult tissues but is expressed in a variety of human tumors. We designed 20-mer phosphorothioate antisense oligonucleotides targeting different regions of
survivin
mRNA and investigated their ability to down-regulate
survivin
mRNA and induce apoptosis in the lung adenocarcinoma cell line A549. Oligonucleotide 4003, which targets nucleotides 23-251 of
survivin
mRNA, was identified as the most potent compound. As measured by real-time PCR, 4003 down-regulated
survivin
mRNA in a dose-dependent manner with an IC50 of 200 nM. Its maximum effect was achieved at a concentration of 400 nM, at which mRNA was down-regulated by 70%. As revealed by increased
caspase-3
-like protease activity, nuclear condensation and fragmentation, and trypan blue uptake, treatment with 4003 induced apoptosis and sensitized tumor cells to the chemotherapeutic agent etoposide. Oligonucleotide 4003 did not reduce the viability of normal blood leukocytes with marginal levels of
survivin
mRNA.
...
PMID:A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. 1085 Apr 18
Using a heterologous yeast expression assay, we show that inhibitor of apoptosis proteins (IAPs) suppress
caspase-3
-mediated cytotoxicity in the order of XIAP>c-IAP2>c-IAP1>
survivin
. The same ordering of IAP activities was demonstrated in mammalian cells expressing an auto-activating
caspase-3
. The relative anti-apoptotic activities of each IAP depended on the particular death stimulus. For IAP-expressing cells treated with camptothecin, survival correlated with their intrinsic anti-
caspase-3
activity. However, c-IAP1-transfected cells were disproportionately resistant to tumor necrosis factor-alpha, suggesting that its anti-apoptotic activities extend beyond
caspase-3
or -7 inhibition. Yeast-based caspase assays provide rapid, reliable information on specificity and activity of the IAPs and aid in identifying critical targets in mammalian apoptotic pathways.
...
PMID:Caspase-3 and inhibitor of apoptosis protein(s) interactions in Saccharomyces cerevisiae and mammalian cells. 1098 7
The human neuronal apoptosis inhibitory protein (NAIP) gene has been discovered as a candidate gene for spinal muscular atrophy, a genetic disorder characterized by motor neuron loss in the spinal cord. The telomeric NAIP gene on human chromosome 5 is deleted together with survival motor neurons (SMN) in many cases of the most severe forms of the disorder. NAIP, c-IAP1 (inhibitor of apoptosis-1), c-IAP2, X-IAP,
survivin
and Apollon comprise the mammalian inhibitors of the apoptosis family and contain an N-terminal domain with 1-3 imperfect repeats of an approximately 65 amino acids domain named the baculovirus IAP repeat (BIR) motif. We identified six NAIP genes in the mouse genome which were found to be expressed in a broad range of tissues. Furthermore, we have investigated the effects of NAIP in the rat pheochromocytoma PC12 cell line. These cells differentiate in the presence of nerve growth factor (NGF) into cells that resemble sympathetic neurons. We observed that NAIP overexpression impaired NGF-induced neurite outgrowth. The BIR motifs of NAIP (residues 1-345) were not required for this effect. However, the BIR domains of NAIP were essential to prevent apoptosis in PC12 cells after NGF deprivation or TNF-alpha receptor stimulation. Expression of full-length but not BIR-deleted-NAIP protects against cell death. This correlates with reduced activity of the cell death effector protease,
caspase-3
, in lysates of NAIP-PC12 cells, as measured by cleavage of the fluorogenic tetrapeptide substrate Asp-Glu-Val-Asp. Thus, unregulation of cellular differentiation and/or caspase suppression may contribute to motoneuron dysfunction and cell death in spinal muscular atrophy where NAIP is mutated.
...
PMID:The neuronal apoptosis inhibitory protein suppresses neuronal differentiation and apoptosis in PC12 cells. 1103 Jul 53
We examined whether
survivin
acts as a constitutive and inducible radioresistance factor in pancreatic cancer cells. Using a quantitative TaqMan reverse transcription-polymerase chain reaction for
survivin
mRNA in five pancreatic cancer cell lines, we found an inverse relationship between
survivin
mRNA expression and radiosensitivity. PANC-1 cells, which had the highest
survivin
mRNA levels, were most resistant to X-irradiation; MIAPaCa-2 cells, which showed the least
survivin
mRNA expression, were the most sensitive to X-irradiation. Our results suggested that
survivin
could act as a constitutive radioresistance factor in pancreatic cancer cells. To determine whether radioresistance is enhanced by induction of
survivin
expression by irradiation, PANC-1 and MIAPaCa-2 cells were subjected to sublethal doses of X-irradiation followed by a lethal dose. Survivin mRNA expression was increased significantly in both PANC-1 and MIAPaCa-2 cell lines by pretreatment with a sublethal dose of X-irradiation, as was cell survival after exposure to the lethal dose. In this system, enzymatic
caspase-3
activity was significantly suppressed in cells with acquired resistance. These results suggest that
survivin
also acts as an inducible radioresistance factor in pancreatic cancer cells. Survivin, then, appears to enhance radioresistance in pancreatic cancer cells; inhibition of
survivin
mRNA expression may improve the effectiveness of radiotherapy.
...
PMID:Survivin as a radioresistance factor in pancreatic cancer. 1109 88
Survivin, an apoptosis inhibitor/cell-cycle regulator, is critically required for suppression of apoptosis and ensuring normal cell division in the G2/M phase of the cell cycle. It is highly expressed in a cell cycle-regulated manner and localizes together with
caspase-3
on microtubules within centrosomes. Whether
survivin
is a physiologically relevant caspase inhibitor has been unclear due to the difficulties with obtaining correctly folded
survivin
and finding the right conditions for inhibition assay. In this study, recombinant, active human
survivin
was expressed in Escherichia coli and purified to homogeneity. The protein, existing as a homodimer in solution, binds
caspase-3
and -7 tightly with dissociation constants of 20.9 and 11.5 nM, respectively, when evaluated by surface plasmon resonance spectroscopy. Consistently,
survivin
potently inhibits the cleavage of a physiological substrate poly(ADP-ribose) polymerase and an artificial tetrapeptide by
caspase-3
and -7 in vitro with apparent inhibition constants of 36.0 and 16.5 nM, respectively. The data suggest that sequestering
caspase-3
and -7 in inhibited states on microtubules is at least one mechanism of
survivin
in the suppression of default apoptosis in the G2/M phase. The localization of
survivin
on microtubules, which is essential for its function, should increase the protective activity at the action site.
...
PMID:An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. 1117 Apr 36
The protective genes that mediate endothelial cell (EC) survival during angiogenesis have not been completely characterized. Here, we show that an antisense oligonucleotide to the apoptosis inhibitor survivin suppressed de novo expression of
survivin
in ECs by vascular endothelial cell growth factor (VEGF). In contrast, the
survivin
antisense oligonucleotide did not affect anti-apoptotic bcl-2 levels in endothelium. When assessed in cell death assays, antisense targeting of
survivin
abolished the anti-apoptotic function of VEGF against tumor necrosis factor-alpha- or ceramide-induced cell death, enhanced
caspase-3
activity, promoted the generation of a approximately 17-kd active
caspase-3
subunit, and increased cleavage of the caspase substrate, polyADP ribose polymerase. In contrast, the
survivin
antisense oligonucleotide had no effect on EC viability in the absence of VEGF. Antisense oligonucleotides to platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31), lymphocyte function-associated molecule-3 (LFA-3, CD58), or intercellular adhesion molecule-1 (ICAM-1, CD54) did not reduce the anti-apoptotic function of VEGF in endothelium. When tested on other angiogenic activities mediated by VEGF,
survivin
antisense treatment induced rapid regression of three-dimensional vascular capillary networks, but did not affect EC migration/chemotaxis. These data suggest that the anti-apoptotic properties of VEGF during angiogenesis are primarily mediated by the induced expression of
survivin
in ECS: Manipulation of this pathway may increase EC viability in compensatory angiogenesis or facilitate EC apoptosis and promote vascular regression during tumor angiogenesis.
...
PMID:Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. 1133 73
1
2
3
4
5
6
7
8
9
10
Next >>